Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis
Clinical trial NCT03710941 · WITHDRAWN
Trial details
- NCT number
- NCT03710941
- Sponsor
- Regeneron Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2020-08-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.